herpes%20simplex%20virus%20infection
HERPES SIMPLEX VIRUS INFECTION
Primary herpes simplex virus (HSV) infection is first infection with either herpes simplex virus-1 (HSV-1) or herpes simplex virus-2 (HSV-2) in individuals who do not have antibodies to either HSV-1 or HSV-2.
First episode-non primary infection is infection with either HSV-1 or HSV-2 in individuals who have previously existing antibodies against HSV-1 or HSV-2 respectively.
Recurrent HSV infection results from reactivation of latent virus. It is usually brought about by triggering factors eg UV light, immunosuppression.
Orolabial HSV disease is mostly caused by HSV-1 that occurs most commonly in children <5 years of age. It is transmitted through close contact with individuals who have active viral shedding.
Genital HSV disease is caused by HSV-2 that is the usual cause of herpes genitalis. It typically occurs in adults and transmitted through sexual contact.

Diagnosis

  • Diagnosis is usually based on distinctive lesions but lab tests may be done if lesions are atypical & if patient has a central nervous system (CNS) disease or severe infection or is pregnant, immunocompromised, or a neonate

Classification

Orolabial Herpes Simplex Virus (HSV) Disease

  • Most orolabial lesions are caused by HSV-1 but may also be caused by HSV-2
    • Recurrent disease tends to occur more frequently w/ HSV-1 infection than HSV-2
  • Occurs most commonly in children <5 years; transmitted through close contact w/ individuals who have active viral shedding
  • May be asymptomatic
  • Painful vesicles & ulcerative lesions on tongue palate, gingiva, buccal mucosa or lips
  • 3-5 lesions typically appear at the vermilion border of the lips (cold sores)
    • Lesions become pustular, ulcerative & crusted w/in 72-96 hours; pain resolves soon after that
  • Edema of oropharynx causes difficulty in swallowing (sore throat)
  • Halitosis
  • Drooling which may bring about lesions in the chin & neck
  • Cervical lymphadenopathy
  • Systemic symptoms: Fever, myalgia, malaise, flu-like symptoms
  • Disease duration: 2-3 weeks

Genital Herpes Simplex Virus (HSV) disease

  • HSV-2 is usually the cause of herpes genitalis but HSV-1 may occur in up to 1/3 of new cases
    • HSV-1 tends to cause fewer recurrences & milder disease than HSV-2
  • Typically occurs in adults; usually transmitted through sexual contact
    • Incubation period is 2 days-2 weeks after exposure, primary lesions appear 4-7 days after contact
  • Local symptoms: Pain, itching, dysuria, vaginal & urethral discharge & tender inguinal lymphadenopathy
  • Systemic symptoms: Fever, headache, myalgia, abdominal pain
  • Lesions may be present in varying stages (vesicles, pustules or ulcers)
  • Primary genital infection is different from recurrent infection in that it is often more painful, extensive, prolonged, likely to be bilateral, & presents w/ lymphadenopathy & systemic symptoms
  • More severe infections & higher rate of complications in women:
    • Lesions occur on vulva, cervix, vagina, clitoris, urethral or perianal skin & extragenital areas eg buttocks, thighs or perineum
    • Painful lesions contain a large amount of infectious viral particles which are excreted over 3 weeks
    • Systemic complications: Urinary retention syndrome, aseptic meningitis, transverse myelitis, sacral radiculopathy, extragenital lesions (buttocks, perineum or thighs), disseminated infections & superinfection w/ bacteria or fungi
  • Infection in men:
    •  Lesions usually occur on the prepuce, glans penis, penile shaft; usually w/ 6-10 vesicles
    •  Perianal infection & proctitis may be common in homosexual men
    •  Systemic complications rarely occur in men, aseptic meningitis is reported
    •  Extragenital areas eg buttocks, perineum or thighs may be affected
  •  Disease duration: 2-4 weeks

Laboratory Tests

Virologic Tests

  • Viral culture
    • Sources of specimens for culture: Skin, mucocutaneous lesions, blood, cerebrospinal fluid (CSF), urine, stool, oropharynx or conjunctiva
    • A positive viral culture will show cytopathic effect characteristic of herpes simplex virus (HSV) replication
    • Test of choice because it is rapid (w/in 7 days), sensitive & allows discrimination between HSV-1 & HSV-2
  • Antigen detection tests
    • Eg immunoperoxidase tests, immunofluorescence, enzyme immunoassay
    • Detect HSV antigens
    • Rapid but do not allow discrimination between HSV-1 & HSV-2
  • Polymerase chain reactions (PCR)
    • Test for HSV DNA
    • Highly sensitive, but its role as a diagnostic test for cutaneous HSV is not well-defined

Type-specific Serologic Tests

  • Eg enzyme-linked immunosorbent assay (ELISA), complement fixation tests, Western blot
  • Do not distinguish anogenital from orolabial infection
  • Immunoglobulin G (IgG) antibody indicates past infection while immunoglobulin M (IgM) antibody suggests recent infection
  • IgM antibody detection lacks sensitivity especially for recurrent infections

Tzanck Smear

  • A Tzanck preparation (Wright-Giemsa stain) may show multinucleated giant cells or intranuclear inclusions from the scrapings from the base of freshly ruptured lesions
  • The method cannot reliably differentiate HSV from varicella-zoster virus
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
30 Nov 2017
Fluarex Tetra - Inactivated quadrivalent influenza vaccine (split virion) vaccine (inj) 0.5 mL - GlaxoSmithKline
02 Nov 2017
In this issue of MIMS Anti-Infective Supplement, we bring you clinical updates related to combating infectious diseases, and also a symposium highlight in conjunction with the launch of ceftolozane/tazobactam (Zerbaxa; Merck Sharp & Dohme Sdn Bhd) in Malaysia. 
30 Oct 2016
Close to a quarter of the world’s population (1.7 billion) were latently infected with Mycobacterium tuberculosis (M.tb) in 2014, according to estimates using mathematical modelling.
10 Sep 2016
More men than women are diagnosed with tuberculosis (TB) in low- and middle-income countries, according to a study. Furthermore, men are also less likely to get access to TB care in many settings.